Analytical Development to Assess T-Cell Therapy Product Potency: A Matrix Approach
Time: 12:00 pm
day: Day 2 - Track A - Morning
Details:
- Understand the FDA draft guidance on cell therapy potency assurance
- Multiple mechanism of action-based assays for TCR T-cell therapies
- Matrix-based potency assessment and its implications
